These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
474 related articles for article (PubMed ID: 25893476)
1. Blood pressure control versus atrial fibrillation management in stroke prevention. Savoia C; Sada L; Volpe M Curr Hypertens Rep; 2015 Jun; 17(6):553. PubMed ID: 25893476 [TBL] [Abstract][Full Text] [Related]
2. The unappreciated importance of blood pressure in recent and older atrial fibrillation trials. Manolis A; Doumas M; Poulimenos L; Kallistratos M; Mancia G J Hypertens; 2013 Nov; 31(11):2109-17; discussion 2117. PubMed ID: 24077242 [TBL] [Abstract][Full Text] [Related]
3. Stroke prevention in elderly patients with atrial fibrillation. Lew SJ; Lim JK Singapore Med J; 2002 Apr; 43(4):198-201. PubMed ID: 12188065 [TBL] [Abstract][Full Text] [Related]
4. Causes of Ischemic Stroke in Patients with Non-Valvular Atrial Fibrillation. Nakamura A; Kuroda J; Ago T; Hata J; Matsuo R; Arakawa S; Kuwashiro T; Yasaka M; Okada Y; Kitazono T; Kamouchi M; Cerebrovasc Dis; 2016; 42(3-4):196-204. PubMed ID: 27111222 [TBL] [Abstract][Full Text] [Related]
5. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey. Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284 [TBL] [Abstract][Full Text] [Related]
6. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban. Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583 [TBL] [Abstract][Full Text] [Related]
7. Secondary prevention of stroke in patients with nonvalvular atrial fibrillation: optimal intensity of anticoagulation. Yasaka M; Yamaguchi T CNS Drugs; 2001; 15(8):623-31. PubMed ID: 11524034 [TBL] [Abstract][Full Text] [Related]
8. Benefits and risks of oral anticoagulation for stroke prevention in nonvalvular atrial fibrillation. Garcia DA Thromb Res; 2012 Jan; 129(1):9-16. PubMed ID: 22018997 [TBL] [Abstract][Full Text] [Related]
9. How do family medicine residents choose an anticoagulation regimen for patients with nonvalvular atrial fibrillation? Yazdan-Ashoori P; Oqab Z; McIntyre WF; Quinn KL; Oosten EV; Hopman WM; Baranchuk A Prim Health Care Res Dev; 2017 Sep; 18(5):472-481. PubMed ID: 28464979 [TBL] [Abstract][Full Text] [Related]
10. Prevention of stroke in patients with atrial fibrillation. Olsson SB; Halperin JL Semin Vasc Med; 2005 Aug; 5(3):285-92. PubMed ID: 16123916 [TBL] [Abstract][Full Text] [Related]
11. Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack. Arima H; Hart RG; Colman S; Chalmers J; Anderson C; Rodgers A; Woodward M; MacMahon S; Neal B; Stroke; 2005 Oct; 36(10):2164-9. PubMed ID: 16141420 [TBL] [Abstract][Full Text] [Related]
12. The cost effectiveness of anticoagulation management services for patients with atrial fibrillation and at high risk of stroke in the US. Sullivan PW; Arant TW; Ellis SL; Ulrich H Pharmacoeconomics; 2006; 24(10):1021-33. PubMed ID: 17002484 [TBL] [Abstract][Full Text] [Related]
13. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation). Patel MR; Hellkamp AS; Lokhnygina Y; Piccini JP; Zhang Z; Mohanty S; Singer DE; Hacke W; Breithardt G; Halperin JL; Hankey GJ; Becker RC; Nessel CC; Berkowitz SD; Califf RM; Fox KA; Mahaffey KW J Am Coll Cardiol; 2013 Feb; 61(6):651-8. PubMed ID: 23391196 [TBL] [Abstract][Full Text] [Related]
14. Stroke prevention in atrial fibrillation: do we still need warfarin? Diener HC; Weber R; Lip GY; Hohnloser SH Curr Opin Neurol; 2012 Feb; 25(1):27-35. PubMed ID: 22143201 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of anticoagulation for secondary stroke prevention in older people with non-valvular atrial fibrillation: a prospective case series study. Tsivgoulis G; Spengos K; Zakopoulos N; Manios E; Peppes V; Vemmos K Age Ageing; 2005 Jan; 34(1):35-40. PubMed ID: 15591481 [TBL] [Abstract][Full Text] [Related]
17. An Update on Anticoagulation in Atrial Fibrillation. Amerena J; Ridley D Heart Lung Circ; 2017 Sep; 26(9):911-917. PubMed ID: 28684097 [TBL] [Abstract][Full Text] [Related]
18. Anticoagulation for stroke prevention in elderly patients with non-valvular atrial fibrillation: what are the obstacles? Wong CW Hong Kong Med J; 2016 Dec; 22(6):608-15. PubMed ID: 27920399 [TBL] [Abstract][Full Text] [Related]
19. Systolic Blood Pressure Visit-to-Visit Variability and Major Adverse Outcomes in Atrial Fibrillation: The AFFIRM Study (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). Proietti M; Romiti GF; Olshansky B; Lip GYH Hypertension; 2017 Nov; 70(5):949-958. PubMed ID: 28974568 [TBL] [Abstract][Full Text] [Related]
20. Cost effectiveness of novel oral anticoagulants for stroke prevention in atrial fibrillation depending on the quality of warfarin anticoagulation control. Janzic A; Kos M Pharmacoeconomics; 2015 Apr; 33(4):395-408. PubMed ID: 25512096 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]